Anavex Life Sciences Corp (AVXL)

[Amatuer17]

It is showing results and they have large sample. Look at the sample size - AVXL does not stand any chance to even consider going to FDA for approval. They will need at least one large trial (LLY has 2 trials going on)

In short - add 4 to 5 years for AD approval - Missling will milk the company and make money

—-

In the primary analysis population (n=1182), the main goal (iADRS) showed 35% slowing of decline, compared to placebo.

Meanwhile, an important secondary goal (Clinical Dementia Rating-Sum of Boxes (CDR-SB) - a measure of disease severity) showed 36% slowing of decline over 18 months.

—-